Volitionrx Ltd
VNRX- Exchange
- NYSE
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000093314
No open-market purchases or sales by Volitionrx Ltd insiders were filed in the last 90 days; 24 institutions reported holding it in 13F filings for Q2 2026, worth $2.61M in total; no superinvestor holds it.
Holders of 5% or more of VNRX
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Volitionrx Ltd, largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Lagoda Investment Management, L.P. | 13D/A | 5.90%1.65M shares | −1.50 ppfrom 7.40% | Feb 16, 202113 filings | Sep 16, 2026 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
23 Schedule 13D and 13G filings on Volitionrx Ltd, newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 16, 20265:30 PM ET | Lagoda Investment Management, L.P.and 2 others | 13D/A | 5.90%1.65M shares | −1.50 ppfrom 7.40% | Sep 15, 2026 | SEC |
| Sep 4, 20265:29 PM ET | Lagoda Investment Management, L.P.and 2 others | 13D | 7.40%1.65M shares | −6.60 ppfrom 14.00% | Aug 17, 2026 | SEC |
| Aug 14, 20264:15 PM ET | Lagoda Investment Management, L.P. | 13G/A | 14.00%1.63M shares | +3.30 ppfrom 10.70% | Jun 30, 2026 | SEC |
| May 15, 20264:05 PM ET | Lagoda Investment Management, L.P. | 13G/A | 10.70%17.1M shares | +0.60 ppfrom 10.10% | Mar 31, 2026 | SEC |
| Feb 17, 20269:38 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 4.99%6.45M shares | −3.73 ppfrom 8.72%Below 5% | Dec 31, 2025 | SEC |
| Feb 17, 20264:30 PM ET | Lagoda Investment Management, L.P. | 13G/A | 10.10%12.5M shares | −1.20 ppfrom 11.30% | Dec 31, 2025 | SEC |
| Nov 14, 20256:29 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 8.72%9.38M shares | −1.27 ppfrom 9.99% | Sep 30, 2025 | SEC |
| Aug 14, 20259:43 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%9.80M shares | 0.00 ppfrom 9.99% | Mar 31, 2025 | SEC |
| Aug 14, 20254:05 PM ET | Lagoda Investment Management, L.P. | 13G/A | 11.30%11.7M shares | +0.74 ppfrom 10.56% | Jun 30, 2025 | SEC |
| May 15, 20253:20 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%9.80M shares | 0.00 ppfrom 9.99% | Mar 31, 2025 | SEC |
| Apr 7, 20254:05 PM ET | Lagoda Investment Management, L.P. | 13G/A | 10.56%10.2M shares | +2.38 ppfrom 8.18% | Mar 31, 2025 | SEC |
| Feb 14, 20255:23 PM ET | Armistice Capital, LLCand 1 other | 13G/A | 9.99%9.34M shares | – | Dec 31, 2024 | SEC |
| Feb 14, 20254:10 PM ET | Lagoda Investment Management, L.P. | 13G/A | 8.18%7.58M shares | – | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Lagoda Investment Management, L.P. | 13GOld format | – | – | – | SEC |
| Nov 14, 2024 | Armistice Capital, LLC | 13GOld format | – | New | – | SEC |
| Feb 14, 2024 | Lagoda Investment Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 9, 2024 | Reynolds Cameron John | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2023 | Lagoda Investment Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2022 | Lagoda Investment Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Mar 1, 2021 | Reynolds Cameron John | 13D/AOld format | – | – | – | SEC |
| Mar 1, 2021 | Innes Guy Archibald | 13D/AOld format | – | – | – | SEC |
| Mar 1, 2021 | Faulkes Martin Charles | 13D/AOld format | – | – | – | SEC |
| Feb 16, 2021 | Lagoda Investment Management, L.P. | 13GOld format | – | New | – | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Volitionrx Ltd shares.
No Form 144 notices for Volitionrx Ltd are on file.